Christian Behrenbruch insider trades: Telix Pharmaceuticals (TLX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christian reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TLX | ↑ Buy | 67,935 | $14.67 | $997K | Elk River Holdings Pty Ltd | May 6, 2026 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLX insiders
Open-market trades in the last 12 months
About Christian Behrenbruch's insider trades
Christian Behrenbruch is MD & Group CEO at Telix Pharmaceuticals (TLX). Since Apr 29, 2026, Christian has reported 1 open-market purchase worth $997K and no sales on SEC Form 4. In the last 12 months: 1 buy ($997K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.